🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cystic Fibrosis (CF)

Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis NCT07809867Phase 41 site📍 Genova Istituto Giannina Gaslini · Tests: Elexacaftor, Tezacaftor, Ivacaftor, Ivacaftor (VX-770) A Study of Females With CF Throughout Pregnancy and Post-partum, and Follow up of Their Offspring NCT06797206n/a1 site📍 London Royal Brompton & Harefield NHS Foundation Trust Estrogen Supplementation and Bone Health in Women With CF NCT05704036Phase 41 site📍 Baltimore Johns Hopkins University · Tests: Transdermal estrogen, Progesterone CF Wellness Program NCT07071324NA3 sites📍 Denver📍 Baltimore📍 Boston Johns Hopkins University · Tests: CF Wellness Program Cystic Fibrosis in the Kidney: Monitoring the Effectiveness of Elexacaftor/tezacaftor/ivacaftor in Urine After a Short Pause of Therapy NCT05818319NA1 site📍 Aarhus C University of Aarhus · Tests: 12 hours ETI pause, 36 hours ETI pause, 60 hours ETI pause Kidney Function in People With Cystic Fibrosis in the Era of HEMT NCT06595420n/a3 sites📍 Birmingham📍 Lebanon📍 Charlottesville University of Virginia Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF) NCT05998629NA1 site📍 Hershey Milton S. Hershey Medical Center · Tests: a skin-interfaced colorimetric bifluidic sweat device with two synchronous channels, Standard of Care laboratory proced… A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF) NCT06526923Phase 1, Phase 24 sites📍 Kansas City📍 Boston📍 New York Spirovant Sciences, Inc. · Tests: SP-101 and doxorubicin Cohort 1, SP-101 and doxorubicin Cohort 2 Study to Enable New Diagnostics for Pulmonary Microbes in People With CF NCT07312734n/a9 sites📍 La Jolla📍 Minneapolis📍 St Louis Chris Goss Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic Fibrosis NCT07569419EARLY Phase 11 site📍 Nottingham University of Nottingham · Tests: Linaclotide 290 micrograms, Lactose placebo pill Lung Transplant READY CF 2: CARING CF Ancillary RCT NCT06032273NA1 site📍 Seattle University of Washington · Tests: Investigator-designed lung transplant education website MAGNIFY - Pulmonary Magnetic Resonance Imaging for Cystic Fibrosis NCT07192679n/a1 site📍 Sheffield Sheffield Teaching Hospitals NHS Foundation Trust Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF) NCT04002882n/a2 sites📍 Birmingham📍 Atlanta Emory University A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators NCT06504589n/a68 sites📍 Birmingham📍 Phoenix📍 Tucson Nicole Hamblett OnTrackCF: Engagement, Feasibility, and Acceptability Study NCT07031323NA3 sites📍 Birmingham📍 Baltimore📍 Boston Boston Children's Hospital · Tests: OnTrackCF PERCE-MUCO: Perceptions and Expectations of People With Cystic Fibrosis Regarding a Change in Treatment NCT07885410n/a11 sites📍 Caen📍 Giens📍 Lille Fondation Ildys Phase 2 Study to Assess the Safety and Efficacy of ANG003 NCT07450547Phase 227 sites📍 Long Beach📍 Los Angeles📍 Denver Anagram Therapeutics, Inc. · Tests: ANG003 Dose A, ANG003 Dose B, Creon Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection NCT07275905Phase 11 site📍 Pittsburgh Ghady Haidar · Tests: AchromoPhage CF Organization of Care in the Era of Highly Effective Modulator. NCT06599892n/a1 site📍 Lyon Hospices Civils de Lyon · Tests: Intervention mapping Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy NCT06996951Phase 31 site📍 Indianapolis Indiana University · Tests: STOP NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID, CONTINUE NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis NCT06487273NA57 sites📍 Abbeville📍 Aix-en-Provence📍 Albi Physio-Assist · Tests: SIMEOX, Remote Physiotherapy A Precision Medicine Approach to Assess Protein Function Loss and the Potential for CFTR Function Restoration in Cystic Fibrosis and Related Disorders NCT07889973n/a3 sites📍 Catania📍 Genova📍 Milan Istituto Giannina Gaslini Modulate-CF: Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant CFTR in Patients With Cystic Fibrosis Treated With CFTR-modulators NCT04732910n/a4 sites📍 Berlin📍 Giessen📍 Hanover Charite University, Berlin, Germany · Tests: Treatment with cystic fibrosis transmembrane regulator (CFTR) modualtors Ivacaftor, Lumacaftor-Ivacaftor, Tezacaftor-Iv… IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study) NCT04294043Phase 110 sites📍 Birmingham📍 Denver📍 Baltimore Chris Goss · Tests: Gallium nitrate Exercises' Effect on Muscle Strength, Aerobic Capacity and Respiratory Functions in Cystic Fibrosis NCT07508904NA1 site📍 Lahore Riphah International University · Tests: Arm Cycle Ergometry, Leg Cycle Ergometry Regional Phenotyping of CF and Non-CF Bronchiectasis NCT04793867n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Xenon Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) NCT06837181n/a18 sites📍 Birmingham📍 Los Angeles📍 Palo Alto Jaeb Center for Health Research · Tests: observational study Development and Validation of a Disease Specific PROM to Assess Abdominal Involvement in Patients With CF (CFAbd-Score) NCT03052283n/a2 sites📍 Brandenburg an der Havel📍 Brandenburg an der Havel Medizinische Hochschule Brandenburg Theodor Fontane · Tests: Questionnaire Patient Reported Outcome Measure (PROM) ACT With CF Self-Help Toolkit NCT07436351NA1 site📍 Philadelphia Thomas Jefferson University · Tests: ACT with CF Self-Help Toolkit, Waitlist Epididymis Protein 4 and Pulmonary Function With Quality Improvement Protocol Among Cystic Fibrosis Patients NCT06915961n/a1 site📍 Cairo Ain Shams University
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy